SEMA3A and osteoporosis: Elucidation of this mechanism not only reveals a new pathway for the superior osteogenic effects of S-EXOs@BMSC but also offers a foundational theory for developing therapies targeting the Sema3A signaling pathway for managing osteoporosis and other conditions affecting bones.